Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of cancer-related deaths globally. Often diagnosed at advanced stages, the therapeutic ...
The TCR repertoire provides a novel platform for investigating the modulation of the TME post-TACE and the underlying mechanisms governing tumor development and recurrence. Clarifying the distinctive ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercode™ BCR and the expansion of its ...
Third Rock Ventures and Parse Biosciences today announced a strategic collaboration to create an unprecedented atlas of 5 million T cell receptors (TCRs) using Parse Biosciences’ GigaLab platform. The ...
leads the IRS market through platforms such as NovaSeq X and AmpliSeq TCR kits, supported by its BaseSpace bioinformatics tools. The company's high-throughput solutions enable comprehensive TCR/BCR ...
Immune low-response states significantly impact the effectiveness of immunotherapy in cancer treatment. These states ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback